81 FR 31248 - Center for Scientific Review; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 96 (May 18, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 96 (May 18, 2016)
| Page Range | 31248-31250 | |
| FR Document | 2016-11662 |
[Federal Register Volume 81, Number 96 (Wednesday, May 18, 2016)] [Notices] [Pages 31248-31250] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-11662] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Community Influences on Health Behavior Study Section. Date: June 9-10, 2016. Time: 8:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Westin Grand, 2350 M Street NW., Washington, DC 20037. Contact Person: Wenchi Liang, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3150, MSC 7770, Bethesda, MD 20892, 301-435- 0681, [email protected]. Name of Committee: Immunology Integrated Review Group; Vaccines Against Microbial Diseases Study Section. Date: June 9-10, 2016. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Jian Wang, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4218, MSC 7812, Bethesda, MD 20892, (301) 435- 2778, [email protected]. Name of Committee: Healthcare Delivery and Methodologies, Integrated Review Group; Biomedical Computing and Health Informatics Study Section. Date: June 9-10, 2016. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Peter J Kozel, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3139, Bethesda, MD 20892, 301-435-1116, [email protected]. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Arthritis, Connective Tissue and Skin Study Section. Date: June 14-15, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Alexey Belkin, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge DR Rm 4102, Bethesda, MD 20817, 301-435-3578, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Cancer Drug Development and Therapeutics. Date: June 14-15, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Lilia Topol, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-451- 0131, [email protected]. Name of Committee: Brain Disorders and Clinical Neuroscience, Integrated Review Group; Clinical Neuroscience and Neurodegeneration Study Section. Date: June 14-15, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Washington, 1515 Rhode Island Ave NW., Washington, DC 20005. Contact Person: Alessandra C Rovescalli, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Rm 5205 MSC 7846, Bethesda, MD 20892, (301) 435-1021, [email protected]. Name of Committee: Vascular and Hematology Integrated Review Group; Hemostasis and Thrombosis Study Section. Date: June 14, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Bukhtiar H Shah, Ph.D., DVM, Scientific Review Officer, Vascular and Hematology IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4120, MSC 7802, Bethesda, MD 20892, (301) 806-7314, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Collaborative Applications: Child Psychopathology. Date: June 14, 2016. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Best Western Tuscan Inn, 425 North Point Street, San Francisco, CA 94133. Contact Person: Jane A Doussard-Roosevelt, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD 20892, (301) 435-4445, [email protected]. Name of Committee: Oncology 1-Basic Translational Integrated Review Group; Tumor Progression and Metastasis Study Section. Date: June 15-16, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Solamar, 435 6th Avenue, San Diego, CA 92101. Contact Person: Rolf Jakobi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6187, MSC 7806, Bethesda, MD 20892, 301-495- 1718, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Cancer Diagnostics and Treatments (CDT). Date: June 15-16, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Zhang-Zhi Hu, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6186, [[Page 31249]] MSC 7804, Bethesda, MD 20892, (301) 594-2414, [email protected]. Name of Committee: Infectious Diseases and Microbiology, Integrated Review Group; Clinical Research and Field Studies of Infectious Diseases Study Section. Date: June 15-16, 2016. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Mclean Tysons Corner, 7920 Jones Branch Dr., Mclean, VA 22102. Contact Person: Soheyla Saadi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301-435- 0903, [email protected]. Name of Committee: Center for Scientific, Review Special Emphasis Panel; Small Business Orthopedic, Skeletal Muscle, and Oral Sciences. Date: June 15-16, 2016. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Aftab A. Ansari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD 20892, 301-237-9931, [email protected]. Name of Committee: Cell Biology Integrated Review Group; Cellular Mechanisms in Aging and Development Study Section. Date: June 16-17, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: John Burch, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3213, MSC 7808, Bethesda, MD 20892, 301-408- 9519, [email protected]. Name of Committee: Center for Scientific, Review Special Emphasis Panel; Small Business: Computational, Modeling, and Biodata Management. Date: June 16, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Allen Richon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892, 301-379- 9351, [email protected]. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Skeletal Biology Structure and Regeneration Study Section. Date: June 16-17, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202. Contact Person: Daniel F McDonald, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4110, MSC 7814, Bethesda, MD 20892, (301) 435-1215, [email protected]. Name of Committee: Cardiovascular and Respiratory Sciences Integrated Review Group; Electrical Signaling, Ion Transport, and Arrhythmias Study Section. Date: June 16, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Chee Lim, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Room 4128, Bethesda, MD 20892, 301-435-1850, [email protected]. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Oral, Dental and Craniofacial Sciences Study Section. Date: June 16-17, 2016. Time: 8:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: Virginia Suites, 1500 Arlington Blvd., Arlington, VA 22209. Contact Person: Yi-Hsin Liu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, 301-435- 1781, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Biophysical, Physiological, Pharmacological and Bioengineering Neuroscience. Date: June 16, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Washington, 1515 Rhode Island Ave, NW., Washington, DC 20005. Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Room 5211, Bethesda, MD 20892, [email protected]. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Synapses, Cytoskeleton and Trafficking Study Section. Date: June 16-17, 2016. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Clayton Plaza Hotel, 7730 Bonhomme Ave, St. Louis, MO 63105. Contact Person: Christine A. Piggee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4186, MSC 7850, Bethesda, MD 20892, 301-435-0657, [email protected]. Name of Committee: Molecular, Cellular and Developmental Neuroscience, Integrated Review Group; Molecular Neuropharmacology and Signaling Study Section. Date: June 16-17, 2016 Time: 8:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Seattle Hotel, 1400 6th Ave, Seattle, WA 98101. Contact Person: Deborah L. Lewis, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD 20892, 301-408-9129, [email protected]. Name of Committee: Molecular, Cellular and Developmental Neuroscience, Integrated Review Group; Neural Oxidative Metabolism and Death Study Section. Date: June 16-17, 2016. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Carol Hamelink, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4192, MSC 7850, Bethesda, MD 20892, (301) 213-9887, [email protected]. Name of Committee: Cell Biology, Integrated Review Group; Biology of the Visual System Study Section. Date: June 16-17, 2016. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Michael H. Chaitin, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5202, MSC 7850, Bethesda, MD 20892, (301) 435-0910, [email protected]. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Molecular Genetics A Study Section. Date: June 16-17, 2016. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue NW., Washington, DC 20037. Contact Person: Michael M. Sveda, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1114, MSC 7890, Bethesda, MD 20892, 301-435-3565, [email protected]. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Genetics of Health and Disease Study Section. Date: June 16-17, 2016. Time: 8:30 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA 22314. Contact Person: Cheryl M Corsaro, Ph.D., Scientific Review Officer, Center for [[Page 31250]] Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD 20892, (301) 435-1045, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Electrical Signaling, Ion Transport and Arrhythmias Special Panel. Date: June 16, 2016. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Abdelouahab Aitouche, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4222, MSC 7814, Bethesda, MD 20892, 301-435-2365, [email protected]. Name of Committee: Center for Scientific Review, Special Emphasis Panel; SBIB Clinical Pediatric and Fetal Applications. Date: June 16, 2016. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: John Firrell, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5118, MSC 7854, Bethesda, MD 20892, 301-435- 2598, [email protected]. Name of Committee: Center for Scientific Review, Special Emphasis Panel, Member Conflict: Neural Trauma and Neurovascular Pathology. Date: June 17, 2016. Time: 1:30 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Alexei Kondratyev, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-435-1785, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: May 12, 2016. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016-11662 Filed 5-17-16; 8:45 am] BILLING CODE 4140-01-P
![31248 Federal Register / Vol. 81, No. 96 / Wednesday, May 18, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Frequency of Time per
Number of
Category of respondent Form name response per response Burden hours
respondents respondent (in hours)
Totals ......................................... ........................................................... 250 ........................ ........................ 42
Dated: May 7, 2016. MSC 7812, Bethesda, MD 20892, (301) 435– MSC 7846, Bethesda, MD 20892, (301) 435–
Karla Bailey, 2778, wangjia@csr.nih.gov. 1021, rovescaa@mail.nih.gov.
Project Clearance Liaison, National Cancer Name of Committee: Healthcare Delivery Name of Committee: Vascular and
Institute, NIH. and Methodologies, Integrated Review Hematology Integrated Review Group;
Group; Biomedical Computing and Health Hemostasis and Thrombosis Study Section.
[FR Doc. 2016–11658 Filed 5–17–16; 8:45 am]
Informatics Study Section. Date: June 14, 2016.
BILLING CODE 4140–01–P Date: June 9–10, 2016. Time: 8:00 a.m. to 6:00 p.m.
Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant
Agenda: To review and evaluate grant applications.
DEPARTMENT OF HEALTH AND applications. Place: Residence Inn Bethesda, 7335
HUMAN SERVICES Place: National Institutes of Health, 6701 Wisconsin Avenue, Bethesda, MD 20814.
Rockledge Drive, Bethesda, MD 20892 Contact Person: Bukhtiar H Shah, Ph.D.,
National Institutes of Health (Virtual Meeting). DVM, Scientific Review Officer, Vascular and
Contact Person: Peter J Kozel, Ph.D., Hematology IRG, Center for Scientific
Center for Scientific Review; Notice of Scientific Review Officer, Center for Review, National Institutes of Health, 6701
Closed Meetings Scientific Review, National Institutes of Rockledge Drive, Room 4120, MSC 7802,
Health, 6701 Rockledge Drive, Room 3139, Bethesda, MD 20892, (301) 806–7314,
Pursuant to section 10(d) of the Bethesda, MD 20892, 301–435–1116, shahb@csr.nih.gov.
kozelp@mail.nih.gov.
Federal Advisory Committee Act, as Name of Committee: Center for Scientific
amended (5 U.S.C. App.), notice is Name of Committee: Musculoskeletal, Oral Review Special Emphasis Panel;
and Skin Sciences Integrated Review Group; Collaborative Applications: Child
hereby given of the following meetings. Arthritis, Connective Tissue and Skin Study Psychopathology.
The meetings will be closed to the Section.
Date: June 14, 2016.
public in accordance with the Date: June 14–15, 2016.
Time: 3:00 p.m. to 5:00 p.m.
provisions set forth in sections Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Agenda: To review and evaluate grant
applications.
applications.
as amended. The grant applications and Place: Bethesda Marriott, 5151 Pooks Hill Place: Best Western Tuscan Inn, 425 North
the discussions could disclose Road, Bethesda, MD 20814. Point Street, San Francisco, CA 94133.
confidential trade secrets or commercial Contact Person: Alexey Belkin, Scientific Contact Person: Jane A Doussard-
property such as patentable material, Review Officer, Center for Scientific Review, Roosevelt, Ph.D., Scientific Review Officer,
and personal information concerning National Institutes of Health, 6701 Rockledge Center for Scientific Review, National
DR Rm 4102, Bethesda, MD 20817, 301–435– Institutes of Health, 6701 Rockledge Drive,
individuals associated with the grant
3578, alexey.belkin@nih.gov. Room 3184, MSC 7848, Bethesda, MD 20892,
applications, the disclosure of which (301) 435–4445, doussarj@csr.nih.gov.
would constitute a clearly unwarranted Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small Name of Committee: Oncology 1-Basic
invasion of personal privacy. Translational Integrated Review Group;
Business: Cancer Drug Development and
Name of Committee: Healthcare Delivery Therapeutics. Tumor Progression and Metastasis Study
and Methodologies Integrated Review Group; Date: June 14–15, 2016. Section.
Community Influences on Health Behavior Time: 8:00 a.m. to 5:00 p.m. Date: June 15–16, 2016.
Study Section. Agenda: To review and evaluate grant Time: 8:00 a.m. to 5:00 p.m.
Date: June 9–10, 2016. applications. Agenda: To review and evaluate grant
Time: 8:00 a.m. to 5:30 p.m. Place: National Institutes of Health, 6701 applications.
Agenda: To review and evaluate grant Rockledge Drive, Bethesda, MD 20892, Place: Hotel Solamar, 435 6th Avenue, San
applications. (Virtual Meeting). Diego, CA 92101.
Place: Westin Grand, 2350 M Street NW., Contact Person: Lilia Topol, Ph.D., Contact Person: Rolf Jakobi, Ph.D.,
Washington, DC 20037. Scientific Review Officer, Center for Scientific Review Officer, Center for
Contact Person: Wenchi Liang, Ph.D., Scientific Review, National Institutes of Scientific Review, National Institutes of
Scientific Review Officer, Center for Health, 6701 Rockledge Drive, Room 6192, Health, 6701 Rockledge Drive, Room 6187,
Scientific Review, National Institutes of MSC 7804, Bethesda, MD 20892, 301–451– MSC 7806, Bethesda, MD 20892, 301–495–
Health, 6701 Rockledge Drive, Room 3150, 0131, ltopol@mail.nih.gov. 1718, jakobir@mail.nih.gov.
MSC 7770, Bethesda, MD 20892, 301–435– Name of Committee: Brain Disorders and Name of Committee: Center for Scientific
0681, liangw3@csr.nih.gov. Clinical Neuroscience, Integrated Review Review Special Emphasis Panel; Small
Name of Committee: Immunology Group; Clinical Neuroscience and Business: Cancer Diagnostics and Treatments
Integrated Review Group; Vaccines Against Neurodegeneration Study Section. (CDT).
Microbial Diseases Study Section. Date: June 14–15, 2016. Date: June 15–16, 2016.
Date: June 9–10, 2016. Time: 8:00 a.m. to 5:00 p.m. Time: 8:00 a.m. to 6:00 p.m.
Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant Agenda: To review and evaluate grant
sradovich on DSK3TPTVN1PROD with NOTICES
Agenda: To review and evaluate grant applications. applications.
applications. Place: Doubletree Hotel Washington, 1515 Place: National Institutes of Health, 6701
Place: Hilton Washington/Rockville, 1750 Rhode Island Ave NW., Washington, DC Rockledge Drive, Bethesda, MD 20892
Rockville Pike, Rockville, MD 20852. 20005. (Virtual Meeting).
Contact Person: Jian Wang, MD, Ph.D., Contact Person: Alessandra C Rovescalli, Contact Person: Zhang-Zhi Hu, MD,
Scientific Review Officer, Center for Ph.D., Scientific Review Officer, National Scientific Review Officer, Center for
Scientific Review, National Institutes of Institutes of Health, Center for Scientific Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218, Review, 6701 Rockledge Drive, Rm 5205 Health, 6701 Rockledge Drive, Room 6186,
VerDate Sep<11>2014 17:10 May 17, 2016 Jkt 238001 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 E:\FR\FM\18MYN1.SGM 18MYN1](https://thefederalregister.org/doc/81_FR_31344/page/1.svg)
![31250 Federal Register / Vol. 81, No. 96 / Wednesday, May 18, 2016 / Notices
Scientific Review, National Institutes of DEPARTMENT OF HEALTH AND The patent rights to these inventions
Health, 6701 Rockledge Drive, Room 2204, HUMAN SERVICES have been assigned to the Government
MSC 7890, Bethesda, MD 20892, (301) 435– of the United States of America.
1045, corsaroc@csr.nih.gov. National Institutes of Health The prospective exclusive start-up
Name of Committee: Center for Scientific licensed territory may be worldwide
Review Special Emphasis Panel; Electrical Prospective Grant of Start-up
and the field of use may be limited to:
Signaling, Ion Transport and Arrhythmias Exclusive License: Development of
‘‘Use of virus like particles comprising
Special Panel. Virus Like Particles for the Treatment
MHCII and CD80 for the treatment of
Date: June 16, 2016. of Breast Cancer, Lung Cancer,
breast cancer, lung cancer, melanoma,
Time: 11:00 a.m. to 1:00 p.m. Melanoma, Pancreatic Cancer, and
pancreatic cancer, and hepatocellular
Agenda: To review and evaluate grant Hepatocellular Cancer
cancer.’’
applications.
Place: Bethesda North Marriott Hotel & AGENCY: National Institutes Of Health, DATES: Only written comments and/or
Conference Center, 5701 Marinelli Road, Public Health Service, HHS. applications for a license which are
Bethesda, MD 20852. ACTION: Notice. received by the NCI Technology
Contact Person: Abdelouahab Aitouche, Transfer Center on or before June 2,
Ph.D., Scientific Review Officer, Center for SUMMARY: This notice, in accordance 2016 will be considered.
Scientific Review, National Institutes of with 35 U.S.C. 209(c)(1) and 37 CFR
Health, 6701 Rockledge Drive, Room 4222,
ADDRESSES: Requests for copies of the
part 404.7, that the National Cancer patent application, inquiries, and
MSC 7814, Bethesda, MD 20892, 301–435– Institute, National Institutes of Health,
2365, aitouchea@csr.nih.gov. comments relating to the contemplated
Department of Health and Human exclusive license should be directed to:
Name of Committee: Center for Scientific Services, is contemplating the grant of a Lauren Nguyen-Antczak, Ph.D., J.D., Sr.
Review, Special Emphasis Panel; SBIB Start-Up Exclusive Patent License to Licensing and Patenting Manager,
Clinical Pediatric and Fetal Applications. practice the inventions embodied in the Technology Transfer Center, National
Date: June 16, 2016. following patent applications to Cancer Institute, 8490 Progress Drive,
Time: 11:00 a.m. to 5:00 p.m. Chimeron Bio Corporation, a company Riverside 5, Suite 400, Frederick, MD
Agenda: To review and evaluate grant incorporated under the laws of 21701; Telephone: (301) 624–8752;
applications. Delaware and having an office in
Place: National Institutes of Health, 6701
Email: lauren.nguyen-antczak@nih.gov.
Philadelphia, PA.
Rockledge Drive, Bethesda, MD 20892. SUPPLEMENTARY INFORMATION: The
Intellectual Property: U.S. Provisional
Contact Person: John Firrell, Ph.D., invention is directed to virus-like
Patent Application No.: 61/615,687
Scientific Review Officer, Center for particles (‘‘VLPs’’) that serve to induce
Entitled ‘‘Delivery of Packaged RNA in
Scientific Review, National Institutes of transgene expression of at least one
Health, 6701 Rockledge Drive, Room 5118,
Mammalian Cells’’ HHS Ref. No.: E–
recombinant protein of interest in
MSC 7854, Bethesda, MD 20892, 301–435–
264–2011/0–US–01 Filed March 26,
specific, targeted cells. This technology
2598, firrellj@csr.nih.gov.
2012; International Patent Application
can be used to treat a variety of diseases,
No.: PCT/US2013/031876 Entitled
Name of Committee: Center for Scientific depending on the cell type to be
‘‘Delivery of Packaged RNA in
Review, Special Emphasis Panel, Member targeted. Preferably, invention VLPs
Mammalian Cells’’ HHS Ref. No.: E–
Conflict: Neural Trauma and Neurovascular may be used to treat tumor bearing
264–2011/0–PCT–02 Filed March 15,
Pathology. cancers, including breast cancer, lung
2013; Australian Patent Application
Date: June 17, 2016. cancer, melanoma, pancreatic cancer,
No.: 2013–240248 Entitled ‘‘Delivery of
Time: 1:30 p.m. to 5:00 p.m. and hepatocellular cancer.
Packaged RNA in Mammalian Cells’’
Agenda: To review and evaluate grant The prospective Start-Up Exclusive
applications.
HHS Ref. No.: E–264–2011/0–AU–03
Filed October 17, 2014; European Patent Patent License, which will be royalty
Place: National Institutes of Health, 6701 bearing, is being considered under the
Rockledge Drive, Bethesda, MD 20892
Application No.: 13712661.1 Entitled
‘‘Delivery of Packaged RNA in small business initiative launched on 1
(Telephone Conference Call). October 2011 and will comply with the
Contact Person: Alexei Kondratyev, Ph.D., Mammalian Cells’’ HHS Ref. No.: E–
264–2011/0–EP–04 Filed October 24, terms and conditions of 35 U.S.C. 209
Scientific Review Officer, Center for
2014; Japanese Patent Application No.: and 37 CFR part 404.7. The prospective
Scientific Review, National Institutes of
2015–503322 entitled ‘‘Delivery of Start-Up Exclusive Patent License may
Health, 6701 Rockledge Drive, Room 5200,
Packaged RNA in Mammalian Cells’’ be granted unless the NIH receives
MSC 7846, Bethesda, MD 20892, 301–435–
HHS Ref. No.: E–264–2011/0–JP–05 written evidence and argument, within
1785, kondratyevad@csr.nih.gov.
Filed September 25, 2014; U.S. Patent fifteen (15) days from the date of this
(Catalogue of Federal Domestic Assistance published notice, that establishes that
Program Nos. 93.306, Comparative Medicine;
Application No.: 14/388,441 Entitled
Delivery of Packaged RNA in the grant of the license would not be
93.333, Clinical Research, 93.306, 93.333, consistent with the requirements of 35
93.337, 93.393–93.396, 93.837–93.844, Mammalian Cells’’ HHS Ref. No.: E–
264–2011/0–US–06 Filed September 26, U.S.C. 209 and 37 CFR part 404.7.
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS) 2014; U.S. Provisional Patent Complete applications for a license in
Application No.: 61/916,394 Entitled the field of use filed in response to this
Dated: May 12, 2016. ‘‘Cancer Immunotherapy: Delivery notice will be treated as objections to
HLA–11 using VLP-Replicon’’ HHS Ref. the grant of the contemplated exclusive
sradovich on DSK3TPTVN1PROD with NOTICES
David Clary,
No.: E–050–2014/0–US–01 Filed start-up license. Comments and
Program Analyst, Office of Federal Advisory
Committee Policy.
December 16, 2013; International Patent objections submitted to this notice will
Application No.: PCT/US2014/070552 not be made available for public
[FR Doc. 2016–11662 Filed 5–17–16; 8:45 am]
Entitled ‘‘Cancer Immunotherapy: inspection and, to the extent permitted
BILLING CODE 4140–01–P Delivery HLA–11 using VLP-Replicon’’ by law, will not be released under the
HHS Ref. No.: E–050–2014/0–PCT–02 Freedom of Information Act, 5 U.S.C.
Filed December 16, 2014; 552.
VerDate Sep<11>2014 17:10 May 17, 2016 Jkt 238001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\18MYN1.SGM 18MYN1](https://thefederalregister.org/doc/81_FR_31344/page/3.svg)
Document Created: 2016-05-18 00:06:44
Document Modified: 2016-05-18 00:06:44
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | June 9-10, 2016. | |
| FR Citation | 81 FR 31248 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR